# Phase 22: Efficacy Test + Version Bump + Tag - Discussion Log

> **Audit trail only.** Do not use as input to planning, research, or execution agents.
> Decisions captured in CONTEXT.md — this log preserves the discussion.

**Date:** 2026-06-27
**Phase:** 22-efficacy-test-version-bump-tag
**Mode:** discuss (orchestrator-driven; skip-assessment applied — standard close, scope fixed by CLOSE-01/02)
**Areas discussed:** Efficacy depth, Tag + push posture

## Questions Asked

### Efficacy depth for the test-sufficiency agent
- **Trigger:** Phase 21's test-sufficiency agent only fires when coverage artifacts exist on
  disk; this repo (a Markdown-orchestration plugin) has none, so the self-dogfood shows the agent
  skipping cleanly rather than catching a real gap.
- **Options presented:** (a) Skip-and-note is sufficient proof [Recommended]; (b) Add a
  synthetic-coverage efficacy check (author a fake lcov/coverage.xml with a known risky gap);
  (c) Decide during DISCUSS.
- **User selection:** Skip-and-note is sufficient proof.
- **Note:** Recorded as D-01. Matches Phase 21's owner-approved D-03 (consume-only narrows
  TESTSUF-02 → skip-and-note is the accepted satisfaction). No synthetic fixture authored.

### Tag + push posture
- **Options presented:** (a) Tag locally, do not push [Recommended]; (b) Tag and push + merge
  feat/v2.5 to main.
- **User selection:** Tag locally, do not push.
- **Note:** Recorded as D-02. Matches the v2.1–v2.4 un-pushed convention; feat/v2.5 stays local.
  Push/merge is a separate owner action.

## Claude's Discretion (left to planning)
- Plan decomposition (likely a single plan — efficacy run + RESULTS-v2.5.md + version bump + tag).
- `/deep-review --all` vs `/review --all` for the dogfood (lean deep — only deep fires
  test-sufficiency, which CLOSE-01 must confirm).
- How no-regression is evidenced (baseline against RESULTS-v2.4.md).

## Deferred Ideas
- Synthetic-coverage efficacy fixture → future milestone if positive-path agent proof is wanted.
- Pushing the tag / merging feat/v2.5 to main → out of scope; separate owner action.

## Orchestrator note
Skip-assessment was applied per the discuss-phase workflow's analyze_phase step 4: Phase 22 is
the well-precedented "standard close" with scope fully fixed by CLOSE-01/CLOSE-02. The only two
genuine product decisions (efficacy depth, tag/push) were surfaced and locked above; no further
gray-area question round was run because none remained.
